Breaking News
Investing Pro 0
💎 Reveal Undervalued Stocks Hiding in Any Market Get Started
Close

AstraZeneca PLC ADR (AZN)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow AstraZeneca ADR's earnings

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
68.73 +0.82    +1.21%
- Closed. Currency in USD ( Disclaimer )
Pre Market
69.19
+0.46
+0.67%
- Real-time Data
Type:  Equity
Market:  United States
  • Volume: 5,708,800
  • Bid/Ask: 0.00 / 0.00
  • Day's Range: 68.61 - 69.26
AstraZeneca ADR 68.73 +0.82 +1.21%

AstraZeneca PLC ADR Company Profile

 
Get an in-depth profile of AstraZeneca PLC ADR, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryPharmaceuticals
SectorHealthcare
Employees

83500

Equity Type

ADR

AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines. The company’s marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Andexxa/Ondexxya, Atacand, Atacand HCT, Atacand Plus, Brilinta/Brilique, Bydureon/Byetta, BCise, Byetta, Crestor, Evrenzo, Farxiga/Forxiga, Komboglyze/Kombiglyze XR, Lokelma, Onglyza, Qtern, Xigduo/Xigduo, and Zestril XR for cardiovascular, renal, and metabolism diseases; Accolate, Accoleit, Vanticon, Bevespi Aerosphere, Breztri Aerosphere, Bricanyl Respules and Turbuhaler, Daliresp/Daxas, Duaklir Genuair, Fasenra, Pulmicort, Rhinocort, Saphnelo, Symbicort, and Tezspire for respiratory and immunology; and Kanuma, Soliris, Strensiq, and Ultomiris for rare diseases. Its marketed products also comprise Synagis for respiratory syncytial virus; Fluenz Tetra/FluMist Quadrivalent for Influenza; and Vaxzevria and Evusheld for covid-19. The company serves primary care and specialty care physicians through distributors and local representative offices in the United Kingdom, rest of Europe, the Americas, Asia, Africa, and Australasia. It has a collaboration agreement with Neurimmune AG to develop and commercialize NI006; and Personalis, Inc. The company was formerly known as Zeneca Group PLC and changed its name to AstraZeneca PLC in April 1999. AstraZeneca PLC was incorporated in 1992 and is headquartered in Cambridge, the United Kingdom.

Contact Information

Address 1 Francis Crick Avenue Cambridge Biomedical Campus
Cambridge, CB2 0AA
United Kingdom
Phone 44 20 3749 5000
Fax -

Top Executives

Name Age Since Title
Leif Johansson 70 2012 Independent Non-Executive Chairman
Pascal Soriot 62 2012 CEO & Executive Director
Aradhana Sarin 47 2021 CFO & Executive Director
Philip Arthur John Broadley 62 2017 Senior Independent Non-Executive Director
Marcus Wallenberg 67 1999 Non-Executive Director
Louise Nicholls - - Member of External Sustainability Advisory Board
Jeffrey Pott - 2009 CHRO, Chief Compliance Officer, General Counsel & Member of External Sustainability Advisory Board
Andreas Rummelt 67 2021 Independent Non-Executive Director
Menelas Pangalos 56 2013 EVP of BioPharmaceuticals R&D and Member of External Sustainability Advisory Board
Deborah DiSanzo Eldracher 63 2017 Independent Non-Executive Director
Shu Kam Mok 61 2019 Independent Non-Executive Director
Nazneen Rahman 55 2017 Independent Non-Executive Director
Rain Henderson - - Member of External Sustainability Advisory Board
Euan A. Ashley 51 2020 Independent Non-Executive Director
Diana Layfield 51 2020 Independent Non-Executive Director
Sherilyn S. D. McCoy 64 2017 Independent Non-Executive Director
Pankaj Bhatia - - Member of External Sustainability Advisory Board
Polly Courtice 71 - Member of External Sustainability Advisory Board
Pam P. Cheng 52 2015 EVP of Operations, IT & Sustainability and Member of External Sustainability Advisory Board
Michel Demare 67 2019 Independent Non-Executive Director
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

AZN Comments

Write your thoughts about AstraZeneca PLC ADR
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Andre Van Laer
Andre Van Laer Mar 23, 2023 2:29PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Why would anyone buy this thing...?
Neek Kajula
Neek Kajula Mar 24, 2022 9:36AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
did they develop a vaccine that works now or why is thos going up?
Hold This Sheet
Hold This Sheet Sep 23, 2021 2:25PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Valneva
damian del
mudlog79 Sep 20, 2021 3:46PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
why this trash going up?
Pascal Torres
Pascal Torres Sep 20, 2021 3:46PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
speculation
Trader Global
Trader Global Sep 03, 2021 12:04AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
already breakout guy.
Adrian Vanyi
Adrian Vanyi Aug 09, 2021 2:45PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
I would await some further drop based on the below article to come in the near future. The company did not perform well with the vaccine and i opened some short positions if my assumptions are correct.
Adrian Vanyi
Adrian Vanyi Aug 09, 2021 2:42PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
https://moneyweek.com/investments/stocks-and-shares/biotech-stocks/603675/astrazenecas-covid-troubles-could-see-it-pull
ray ford
ray ford Jun 30, 2021 8:47AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
hold long = big victory ✌
Leo Mu
Leo Mu Jun 28, 2021 3:49PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Finally it reached $60+.
Leo Mu
Leo Mu Jun 24, 2021 9:39AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
AZN and MRK: Lynparza approved in China for the treatment of BRCA-mutated metastatic castration-resistant prostate cancer. Support is strong for the 2 stocks.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email